Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24098589 | 0.80 | L3MBTL1 (0.31) | L3MBTL1 | |
| SCHEMBL24172658 | 0.73 | — | — | |
| SCHEMBL8963078 | 0.72 | — | — | |
| SCHEMBL7627510 | 0.71 | TLR4 (0.33) | TLR4NPC1L3MBTL1MAPTRAB9A | |
| SCHEMBL7627513 | 0.71 | TLR4 (0.33) | TLR4NPC1L3MBTL1MAPTRAB9A | |
| SCHEMBL10160080 | 0.68 | — | — | |
| SCHEMBL20231417 | 0.68 | — | — | |
| SCHEMBL6727176 | 0.68 | — | — | |
| SCHEMBL2080517 | 0.68 | — | — | |
| SCHEMBL12210527 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270883-A1 | ACTIVE AGENT RELEASE PARTICLE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-08-31 | — | — | US | disclosed |
| WO-2022034339-A1 | ACTIVE AGENT RELEASE PARTICLE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270883-A1 | ACTIVE AGENT RELEASE PARTICLE | AIFM2, ACR, SLC40A1 | TLR4 3236/4885NPC1 3428/4885L3MBTL1 2343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.